105 related articles for article (PubMed ID: 26089500)
1. IMMUNOLOGY. A Chlamydia vaccine on the horizon.
Brunham RC
Science; 2015 Jun; 348(6241):1322-3. PubMed ID: 26089500
[No Abstract] [Full Text] [Related]
2. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.
Stary G; Olive A; Radovic-Moreno AF; Gondek D; Alvarez D; Basto PA; Perro M; Vrbanac VD; Tager AM; Shi J; Yethon JA; Farokhzad OC; Langer R; Starnbach MN; von Andrian UH
Science; 2015 Jun; 348(6241):aaa8205. PubMed ID: 26089520
[TBL] [Abstract][Full Text] [Related]
3. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
Rey-Ladino J; Ross AG; Cripps AW
Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
[TBL] [Abstract][Full Text] [Related]
4. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
[TBL] [Abstract][Full Text] [Related]
5. Towards a Chlamydia vaccine. Interview by Kelly McCauley.
Igietseme J
Expert Rev Vaccines; 2004 Jun; 3(3):237-42. PubMed ID: 15176940
[No Abstract] [Full Text] [Related]
6. Considerations for the rational design of a Chlamydia vaccine.
Liang S; Bulir D; Kaushic C; Mahony J
Hum Vaccin Immunother; 2017 Apr; 13(4):831-835. PubMed ID: 27835064
[TBL] [Abstract][Full Text] [Related]
7. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
[TBL] [Abstract][Full Text] [Related]
8. Towards a Chlamydia trachomatis vaccine: how close are we?
Cochrane M; Armitage CW; O'Meara CP; Beagley KW
Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
[TBL] [Abstract][Full Text] [Related]
9. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
[TBL] [Abstract][Full Text] [Related]
10. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Brunham RC; Rey-Ladino J
Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
[TBL] [Abstract][Full Text] [Related]
11. Action Needed on Chlamydia Vaccines.
Starnbach MN
Trends Microbiol; 2018 Aug; 26(8):639-640. PubMed ID: 29858127
[TBL] [Abstract][Full Text] [Related]
12. The potential for vaccine development against chlamydial infection and disease.
Brunham RC; Zhang DJ; Yang X; McClarty GM
J Infect Dis; 2000 Jun; 181 Suppl 3():S538-43. PubMed ID: 10839755
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
[TBL] [Abstract][Full Text] [Related]
14. Chlamydial genomics and vaccine antigen discovery.
Stephens RS
J Infect Dis; 2000 Jun; 181 Suppl 3():S521-3. PubMed ID: 10839752
[TBL] [Abstract][Full Text] [Related]
15. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
[TBL] [Abstract][Full Text] [Related]
16. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
[TBL] [Abstract][Full Text] [Related]
17. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis.
Grayston JT; Wang SP
Sex Transm Dis; 1978; 5(2):73-7. PubMed ID: 10328037
[No Abstract] [Full Text] [Related]
18. Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.
Karunakaran KP; Yu H; Jiang X; Chan Q; Moon KM; Foster LJ; Brunham RC
Vaccine; 2015 Apr; 33(18):2159-66. PubMed ID: 25738816
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.
Jiang P; Cai Y; Chen J; Ye X; Mao S; Zhu S; Xue X; Chen S; Zhang L
Vaccine; 2017 May; 35(23):3096-3103. PubMed ID: 28456528
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia trachomatis control requires a vaccine.
Brunham RC; Rappuoli R
Vaccine; 2013 Apr; 31(15):1892-7. PubMed ID: 23375977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
